We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Vir Biotechnology, Inc. (NASDAQ:VIR) stands against the other ...

Vir Biotechnology Inc (VIR) stock saw a modest uptick, ending the day at $11.2 which represents a slight increase of $0.67 or 6.36% from the prior close of $10.53. The stock opened at $10.48 and ...

At the conference last week in San Francisco, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Dr Rajesh Gupta, vice president, global health portfolio and public-private partnerships at Vir Biotechnology, said: “COVID-19 reinforced the ever-present global threat of infectious diseases ...

Aware of the high-tech workforce shortage amid tech giants flocking to Vietnam, the government has proposed training roadmaps alongside direct initiatives by tech corporations, with a strong focus on ...

Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar rating. The main driver of the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by ...

This post was written by Luke Carberry Mogan. If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of ...

Final Synthetic Yeast Chromosome Unlocks New Era in Biotechnology Jan. 22, 2025 — Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome ...

Predators at the top of a marine food chain 130 million years ago ruled with more power than any modern species, McGill research into a marine ecosystem from the Cretaceous period revealed.